Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P21
Within normal range
vs 5Y Ago
-6.7x
Contraction
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-123.92M | +41.6% |
| 2024 | $-212.25M | +22.9% |
| 2023 | $-275.39M | +1.7% |
| 2022 | $-280.14M | -139.2% |
| 2021 | $-117.11M | -734.3% |
| 2020 | $18.46M | +122.8% |
| 2019 | $-81.15M | -18.8% |
| 2018 | $-68.28M | +12.4% |
| 2017 | $-77.95M | -2.4% |
| 2016 | $-76.14M | - |